Episode 327

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof John Seymour, including the following topics:

  • Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
  • Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
  • First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
A Research To Practice Podcast for Oncology Clinicians

Listen for free